The constant drive towards a more personalized medicine led to an increasing interest in temporal gene expression analyzes. It is now broadly accepted that considering a temporal perpective represents a great advantage to better understand disease progression and treatment results at a molecular level. In this context, biclustering algorithms emerged as an important tool to discover local expression patterns in biomedical applications, and CCC-Biclustering arose as an efficient algorithm relying on the temporal nature of data to identify all maximal temporal patterns in gene expression time series. In this work, CCCBiclustering was integrated in new biclustering-based classifiers for prognostic prediction. As case study we analyzed multiple gene expression time series in order to classify the response of Multiple Sclerosis patients to the standard treatment with Interferon-β, to which nearly half of the patients reveal a negative response. In this scenario, using an effective predictive model of a patient's response would avoid useless and possibly harmful therapies for the non-responder group. The results revealed interesting potentialities to be further explored in classification problems involving other (clinical) time series.
Background
In the last decade, several techniques to evaluate gene expression became available, such as microarrays, which measure, instantly, the expression level of up to thousands of genes (possibly, all genes in a genome), and more recently RNA seq technologies for transcriptomic profiling. Gene expression experiments were, until more recently, limited to a static analysis, in which only a snapshot of the gene expression for a set of samples was available. However, the last years have witnessed an increase in time-course gene expression experiments and analysis. In fact, being able to study the temporal dynamics of gene expression is now enabling the study of complex biomedical problems, such as disease progression and drug response, from a different perspective. Studying these data is however challenging, both from a computational and biomedical point of view [1, 2] .
Biclustering algorithms have been recognized as an important tool for the discovery of local expression patterns [3] . Given the known importance of discovering local temporal patterns of expression in both biological and clinical applications [1, 2, 4, 5] , recent biclustering approaches have addressed this problem in the specific case of time series expression data [6] . In fact, recent research on biclustering algorithms showed that although most of the biclustering problems are NP-hard, when working with expression time series the interesting biclusters are those with coherent evolutions on the columns [6] . This restriction leads to a tractable problem.
In this work, we use CCC-Biclustering [6] , which finds all maximal contiguous column coherent (CCC) biclusters (subsets of genes with coherent expression patterns in contiguous subsets of time-points) by analyzing a discretized version of the expression matrix using efficient string processing techniques based on suffix trees. We propose a set of new biclustering-based classifiers, where CCC-Biclusters are used as the class discriminative features. We use as case study the prognostic prediction in patients with Multiple Sclerosis (MS) in response to the Interferon (IFN)-β standard treatment, using data from Baranzini et al. [7] .
The main advantage of the proposed biclustering-based classifier lies on the interpretability of the results. In this case, the class-discriminant features are the biclusters, identifying subsets of genes coherently expressed over a subset of contiguous time-points, thus pinpointing potentially relevant biological processes related to disease progression and/or drug response. This information can be directly analyzed, while this is not possible or straightforward for other classifiers using gene expression time series [4, 5, 7] . The most limiting aspect of the proposed biclustering-based supervised learning approach might be the required discretization step, which conceals a risk of losing important information. However, a possibility to overcome this drawback might reside in an increase in the number of symbols used in the discretization step yielding more and thus more specific biclusters, while maintaining the efficiency of biclustering and the interpretability of the classification results. We note that the discretization step is key to guarantee the completeness and the efficiency of the biclustering algorithm, which would otherwise have to rely on heuristics.
Multiple Sclerosis
MS can be defined as a chronic inflammatory disease, characterized by a demyelinating disorder of the central nervous system (CNS) [8] . Although its etiology remains, to date, still far from total understanding, the interrelation of both genetic and environmental factors is believed to be crucial to the development of MS. A major factor to be considered in this regard is the phenotypic heterogeneity in MS, where different pathologic patterns may indicate differences in the pathogenic mechanisms [8] . Moreover, the search for single candidate genes that could account for the disease development is still unfruitful. The main conclusion is that MS is genetically complex, and thus it is not possible to select single genes to explain a person's susceptibility, since this might be a result of the interaction of several altered genes [8] . Consequent to the heterogeneity of the disease, the treatment response, even for one stage of MS only (relapsing-remitting (RR) MS), presents a high variability, suggesting different responses at the molecular level, leading to diverse clinical outcomes as the inhibition of the CNS inflammation [9] . Nevertheless, the treatment of RR-MS patients has routinely been carried with the use of recombinant human IFN-β [7] . However, up to half the patients show no benefits from this treatment, and negative side effects, such as flu-like symptoms and tissue damage, have to be considered [5] . Thus, the main goal of a time-course profiling of the treatment response of MS patients rests, as can be anticipated, in the possibility of accurately predicting a given patient's response, avoiding useless and possibly harmful treatments.
Related Work
Biclustering has been recently used in several data mining tasks, such as collaborative filtering [10] and bioinformatics, as is the case of miRNA based tumor classification [11] . Nevertheless, to our knowledge, biclustering was not used before in classification problems involving clinical expression time series. In what concerns the dataset used in this work, it has already been studied by other authors over the last years, whose work we briefly describe below.
Baranzini et al. [7] collected a dataset containing the profiling of MS patients subjected to IFN-β therapy. These authors proposed a quadratic analysis-based integrated Bayesian inference system (IBIS) to analyze it. They chose the best discriminative triplets of genes, obtaining a prediction accuracy up to 86% for a gene triplet consisting of Caspase 2, Caspase 10 and FLIP. We note, however, that in this work only the first time-point was considered. Lin et al. [4] proposed a new classification method, based on Hidden Markov Models (HMMs) with discriminative learning (using both positive and negative examples). In this work, the analysis was preceded by a feature selection step, to eliminate the least discriminative genes. The main results of applying this method to the MS dataset for two to seven time points were a prediction accuracy of up to 88%, and most importantly, the consideration and identification of patient-specific response rates. Finally, Costa et al. [5] introduced the concept of constrained mixture estimation of HMMs and applied it to the MS dataset. The constraints were positive when two patients were forced to be associated in the same group, or negative when they were not allowed to be grouped together. A preprocessing feature selection step was also performed. The main results include a prediction accuracy over 90% and the possibility of subgroup classification (two subgroups of good responders). This method also suggested the existence of one mislabeled patient, which was confirmed by Baranzini et al. [7] .
Methods
In this section, we present the new biclustering-based classification strategies developed in this work: k-Nearest Neighbors (kNN) with different similarity measures and a meta-profiles classifier. We start by explaining CCC-Biclustering, an algorithm specifically proposed to analyze expression time series, used as part of the proposed classifiers. Figure 1 shows their workflow.
CCC-Biclustering
Let A be an N G rows by N T columns gene expression matrix defined by its set of rows (genes), G, and its set of columns (time-points), T . In this context, A ij represents the expression level of gene i in time-point j. We address the case where gene expression levels in matrix A can be discretized to a set of symbols, Σ, that represent distinctive activation levels. After the discretization process, matrix A is transformed into matrix A, where A ij ∈ Σ represents the discretized value of the expression level of gene i in time-point j. In Figure 2 a three symbol alphabet Σ = {D, N, U } was used, where 'D' (down), 'N ' (no-change), and 'U ' (up) mean that the expression levels decreased, didn't change or increased between consecutive time-points T j and T j+1 . When T j , T j+1 or both are missing, the symbol '−' is used. The goal of biclustering algorithms is to identify a set of biclusters B k = (I k , J k ) such that each bicluster satisfies specific characteristics of homogeneity [3] . For time series gene expression data analysis, Madeira et al. [6] defined the concept of CCC-Bicluster as follows: A contiguous column coherent bicluster (CCC-Bicluster) A IJ is a subset of rows I = {i 1 , . . . , i k } and a subset of contiguous columns J = {r, r + 1, . . . , s − 1, s} such that A ij = A lj , ∀i, l ∈ I and ∀j ∈ J. A CCC-Bicluster defines a string, common to every row in I for the columns in J.
A CCC-Bicluster A IJ is maximal if no other CCC-Bicluster exists that properly contains
Consider now the matrix obtained by preprocessing matrix A using a simple alphabet transformation, that appends the column number to each symbol in the matrix and the generalized suffix tree built for the set of strings corresponding to each row in A. CCC-Biclustering is a linear time biclustering algorithm that finds and reports all maximal CCC-Biclusters based on their relationship with the nodes in the generalized suffix tree (see [6] for details and Figure 2 ). Figure 2 : Maximal CCC-Biclusters in the discretized matrix and related nodes in the suffix tree.
Biclustering-based k-Nearest Neighbors
The kNN algorithm is a simple supervised learning method, whose goal is to classify an object based on the k closest training instances. The k parameter is a positive integer, usually small, chosen empirically with the help of some cross validation schemes, for example. In order to favor the best scoring instances, a distance-weighted algorithm can be used. The weights can be a function of their rank (with a weight of 1/d, d being the rank or the distance to the test object). Algorithm 1 shows the biclustering-based kNN algorithm used to classify patient prognosis.
Algorithm 1: Biclustering-based kNN
Input : Score matrix between patients: S Output: predictedClass foreach test patient do build list with k highest scoring train patients → kP atients from kP atients, compute the sum of the scores for each of the N classes: scores n , n ∈ 0, ..., N predictedClass = arg max (scores n ), n ∈ 0, ..., N
Score Matrix based on Biclusters Similarities
The matrix that represents the relationship between test and train patients, from which the k most similar train patients are selected to classify each test patient, is the score matrix (the higher the score, the higher the degree of similarity between the patients). It has as many rows as the number of train patients, and a number of columns equal to the number of test patients.
To reduce the effects of unbalanced data, as is the case in the case study used in this work, a penalty/weight can be included in the computation of this matrix, a fraction which alters the actual score between the two patients: InitialScore × penalty = W eightedScore.
The entry (i, j) of the score matrix between patients represents the degree of similarity between a bicluster B i from the set of biclusters of a test patient, and a bicluster B j from the set of biclusters of a train patient. This similarity can be computed from the fraction of common elements between the two biclusters, using an adapted version of the Jaccard Index, used by Madeira et al. [6] , where we include the information of the genes expression variation, since we are comparing biclusters from different patients. However, it is necessary to transform this measure of similarity between two patients into a single score value, to proceed with kNN classification. This transformation is performed as follows:
where Sim(B i , B j ) is the similarity between biclusters B i and B j , and #B test and #B train represent the number of biclusters of, respectively, the test and train patient, P test and P train .
Score Matrix based on Profiles Similarities
Another strategy to compute the score matrix between the test patients and the training set relies on the fact that each CCC-Bicluster is represented by a pattern of symbols, a profile, representative of the coherent evolution in the expression of the genes in the bicluster along the bicluster time-points. A profile is said to be shared between patients if it identifies a similar expression pattern and represents biclusters which have the required minimum number of genes and/or time-points in common, a parameter determined empirically.
The score matrix between patients is computed, such that an entry (i, j) represents the number of profiles shared between train patient i and test patient j. Instead of the sum of shared profiles between patients, the entry (i, j) of the score matrix can also be computed with a polynomial kernel (a quadratic kernel in general). The idea is to penalize the patients with a larger number of biclusters, since a higher number of profile matches could be due to random events.
Filtering Non-Discriminative Biclusters based on Profiles
A given profile is kept in the filtered set, if and only if it contributes more to the discrimination than to the confusion between classes, that is, a profile in a train patient's set of profiles is maintained if and only if it is shared by more patients of the same class than of the other class. A minimum number of shared genes and/or time-points can also be used and fine-tuned.
Score Matrix based on Symbol Pairing with Time-Lags
As one might expect, even when the same genes are involved in a given mechanism in different patients, the expression evolution pattern for one patient might be delayed when compared to others'. As such, the possibility of time-lags in gene expression should be taken into account, as it is a consequence of the patient-specific response rate, and shown to be of particular importance in previous time series expression studies [4] . In this approach, all biclusters (or filtered ones) of the test patient are analyzed and a parameter for a maximum time-lag (number of time-points to consider in the delay) is defined. Then, for each test bicluster, a comparison is made between the discretized symbols, computing the number of perfect matches, considering translations in the time-points, from 0 (the original position) to the maximum time-lag, and its symmetric, thus allowing translations in both directions along the time axis (Figure 3 ). The time-lag returning the highest score is chosen, and the binary submatrix resulting from that specific comparison is written in a final matrix. The sum of this matrix represents the score between the two patients, the entry (i, j) of the score matrix for the whole set of patients.
Figure 3: Symbolic comparison between a test bicluster (on the right) and the train discretized expression matrix (on the left). In this case, the highest scoring time-lag is +1 corresponding to shifting the test bicluster one position to the right, where a perfect symbol match is achieved with the symbols shaded green on the left, identifying a delayed expression profile between the patients.
Meta-Profiles Classification
Having explored different strategies to combine biclustering and kNN classification, we now present a new classification approach following the biclusters computation. It is based on the mentioned fact that each bicluster identifies a pattern of temporal evolution in terms of gene expression, which is represented by a profile. A meta-profile represents a set of similar profiles.
In this approach, presented in Algorithm 2, the goal is to analyze if a given profile is shared between more patients of one of the classes.
For example, if a train profile is shared only between good responders, then if a test patient shows an equivalent expression profile, the probability of this patient being a good responder increases. In this method, the class proportions for each profile of a test patient contribute for the patient classification, in a weighted-voting scheme. Due to the difference in the class distributions, a penalty can also be introduced here to soften the classification.
Algorithm 2: Meta-Profiles Classification
Input : Meta-Profiles space: list with the profiles of all computed biclusters Output: predictedClass foreach meta-profile m do foreach train patient tp do T rainIndexes ← {} if meta-profile m ∈ set of profiles of tp then add tp to T rainIndexes compute class proportions of meta-profile m for each of the N classes: P roportions n , n ∈ 0, ..., N foreach test patient i do foreach test profile p do if p ∈ meta-profiles space then associate respective class proportions to p compute the sum of class proportions for all test profiles: sumP roportions n , n ∈ 0, ..., N predictedClass = arg max (sumP roportions n ), n ∈ 0, ..., N In the case study, the performed tests revealed that the best discriminative criterion was that the patients with more balanced class proportions were classified as good responders (class 1). This corresponds to the following classification criterion, when two classes are considered:
if sumP roportions 1 × penalty < sumP roportions 0 then predictedClass = 1; else predictedClass = 0;
Results and Discussion
In this section, we present and discuss the specificities of the case study used in this work, including the dataset description and preprocessing, as well as the evaluation strategies used. We discuss the main results obtained with the proposed classification approaches, as an indicator of the classifiers' performance, in different contexts. This includes an evaluation on the effect of feature selection and an analysis of the classifiers' performance when different time-points are used. We also compare the biclustering-based classifiers with state-of-the-art classifiers, using both the real-valued and a discretized version of the dataset. Finally, and in the case of the meta-profiles classifier, we discuss the biomedical interpretation of the results by analyzing the genes which occur more often in the most class-discriminant biclusters.
Dataset
The dataset used as case study in this work was collected by Baranzini et al. [7] . Fifty two patients with RR-MS were followed for a minimum of two years after the treatment initiation. After that time, patients were classified according to their response to the treatment, as good or bad responders. Thirty two patients were considered good responders, while the remaining twenty were classified as bad responders to IFN-β therapy. Seventy genes were pre-selected based on biological criteria, and their expression profile was measured in seven time-points (initial point, and three, six, nine, twelve, eighteen and twenty-four months after treatment initiation), using one-step kinetic reverse transcription PCR [7] .
Preprocessing
In order to apply CCC-Biclustering [6] as part of the proposed biclustering-based classifiers, we normalized and discretized the expression data. The discretization was performed by computing variations between time-points as carried by Madeira et al. [6] , thus resulting in patterns of temporal gene expression evolution with three symbols: decrease ('D'), no change ('N ') and increase ('U '). In the case of standard classifiers, not able to deal with missing values directly, these were filled with the average of the closest neighboring values, after data normalization. In the biclustering-based classifiers proposed in this work, the CCC-Biclustering algorithm is able to handle missing values directly. However, for comparison purposes, the results shown were obtained with filled missing values, even for the biclustering-based classifiers.
Evaluation
Since we are dealing with a classification task to predict a given patient's response to a MS treatment, the evaluation of any method must be based on the algorithm capability to predict the response class of a new MS patient, based on similar data used to train the classifier. For a finite dataset, the prediction accuracy is defined as the percentage of correctly predicted instances. However, to extract more information about the performance of a classifier, we use the confusion matrix, which accounts for the number of correctly classified instances for each class, allowing the computation of two important ratios: True Positive Rate -the ratio of correctly classified instances of class 1 (good responder), and False Positive Rate -the ratio of incorrectly classified instances of class 0 (bad responder). Furthermore, using these two ratios as data points, we are able to construct the Receiver Operating Characteristics (ROC) curve. This provides information about a classifier's performance for all misclassification costs, and all possible class ratios. When only a few (FP, TP) pairs are available, we use an interpolated curve corresponding to an approximate ROC curve.
Cross-validation
A commonly used strategy to evaluate accuracy estimation is the k-fold cross validation (CV) scheme, where dataset D is randomly partitioned into k mutually exclusive subsets, of (approximately) equal size : D 1 , ..., D k . Then, for each fold (1 to k), the classifier is trained with the k − 1 remaining subsets, and tested with subset D k . This is repeated k times, and the overall prediction accuracy estimate is the mean prediction accuracy for all k folds. When k equals the number of instances in the dataset, the term Leave-one-out (LOO) CV is used, since one instance is left out to test the classifier, while all the others constitute the train set. When the class proportions in the original dataset are maintained in the subsets or folds, the term stratified CV is used. In this work, we use both LOO and 5 repetitions of stratified 4-fold CV. Table 1 summarizes the prediction accuracies obtained for the proposed biclustering-based classifiers. Figure 4 shows the confusion matrix and approximate ROC curve for the meta-profiles classification method (sum criterion with penalty = 61.4%, using the best 90% of computed biclusters, in terms of p-value, as computed in [6] ). This classifier achieved a prediction accuracy of 94.23% for LOO CV. We note, however, that with 5 x 4-fold CV, the prediction accuracy dropped below 68%. This fact might be justified by an optimistic value of LOO CV due to data overfitting, or to the small size of the dataset. In fact, in a 4-fold CV with 52 patients, the test set has 13 patients, significantly reducing the training set. Thus, important information to accurately compute the profile proportions between classes might be lost. At this point it is important to emphasize particular characteristics of this dataset. Besides class unbalance, we can find considerable differences between what is shared between the patients of the two response classes: good responders have a significant number of similar biclusters in common with other good responders, but also with the bad responders. These shared similar biclusters might include characteristic disease expression signatures, common to all RR-MS patients, a fact that shall be further investigated. Bad responders, however, show evidences of having few similar biclusters in common, beside the ones also shared with the good responders group. This fact suggests that there are different expression signatures associated to a poor response to IFN-β treatment or an absence of signature present in good responders, a probable result of differences in the fragile balance of several pathways associated to the disease and/or treatment response. This might justify the used criterion in the meta-profiles method, which led to a prediction accuracy up to 94.23%. Even in this scenario, some of the proposed classifiers revealed potentialities which are worth exploring. We highlight the computation of the score matrix using symbol pairing with timelags, since simply considering time delays improved significantly the prediction accuracy (pvalue =0.0025, paired t-test). The best predictor was the biclustering-based meta-profiles classifier, where the used criterion was opposite to the generally expected. This might be a result of data specificities, and should be further analyzed, especially regarding its lower specificity: a permutation test, shuffling the class labels 1000 times, returned a drop in the prediction accuracy of approximately 15%.
Performance
It was not possible to reproduce previous results on the MS dataset [5] , due to serious difficulties in getting access and running the classifiers, or even to obtain the test/train sets. This led to the choice of comparing our results only with standard classifiers. This was performed using Weka (www.cs.waikato.ac.nz/ml/weka). Instead of a matrix per patient, the dataset used in this situation consists of a single matrix where each row represents the data for a single patient, with 7 blocks (number of time-points) of 70 expression values each (number of genes). This means that the expression values of all genes for a given time-point are grouped together in the matrix, and each of its entries (P,J), with J = GT represents the expression value of a gene G in a time-point T for a patient P . Nonetheless, with the exception of meta-profiles, the prediction accuracies obtained by the other proposed biclustering-based classifiers are lower than the results reported (but not reproducible) in the literature for this dataset [4, 5, 7] . We note, however, that all these approaches used feature selection by first selecting a small set of genes. We also performed experiments with real-valued gene expression matrices using feature selection as a preprocessing step achieving a 5 x 4-fold cross validation accuracy rate of 95.77% with a SVM classifier using a quadratic kernel. We consider this approach, using feature selection as a preprocessing step, to be biased since it uses information of data that is going to be part of test sets in the cross validation strategy. Therefore the results in Table 2 were obtained using a strategy in which we applied feature selection in each step of cross validation and only using training data. Table 2 shows the best prediction accuracies obtained for the different state of the art classifiers in the real-valued expression data, together with the best prediction accuracies in a discretized version of the expression data. We aimed to assess the influence of the discretization process used in the biclustering-based classifiers. We show that standard classifiers tested on the real-valued dataset outperformed most of the biclustering-based classifiers, excluding the meta-profiles method. It is also possible to observe that the standard decision trees prediction accuracy is not significantly higher (p-value > 0.16, paired t-test) than the one of the biclustering-based kNN based on symbol pairing with a maximum time-lag of one time-point in each direction (mean prediction accuracy of 69.23% (LOO) and 68.08% (5 x 4-fold)). It is also shown that the use of a discretized version of data lowers the classifiers' performance significantly (p-value < 0.05 for all classifiers, paired t-test). These evidences suggest that this kind of classifiers cannot deal well with discretized data of this type (especially with the significant differences in what is shared between patients of different classes). In fact, the biclustering-based kNN classifier based on symbol pairing with time-lags outperformed significantly all these standard classifiers (p-value < 0.05, paired t-test) when acting upon discretized data. The superiority of the meta-profiles classifier was even more evident.
Although the precision accuracies obtained for the MS dataset are not as high as desired, we highlight that IFN-β therapy is, currently, the standard treatment for MS. Therefore, if a classifier is able to correctly predict the patients response in a percentage higher than the proportion of good responders in the population, then it presents a significant advantage. However, we must contrast the case of false positives (bad responders classified as good responders, thus receiving the treatment) and false negatives (good responders missing the treatment). Given the negative side effects and the arising of alternative therapies, the classification should favor the bad response classification. This means that we should minimize the false positive rate, thus avoiding useless and possibly harmful treatments, allowing for the patients to an earlier change to different forms of treatment, potentially more effective for their particular situation.
Feature Selection
The dataset characteristics points to an overfitting of the data, since there are many more genes than time-points. In this scenario, feature selection can be used to reduce the number of genes used in the classification in attempt to minimize overfitting. Thus, we resorted to the reduced set of genes found by Costa et al. [5] , which consists of 17 genes out of all the 70 initial ones. We note, however, that the algorithm used to compute this reduced set was built to find the genes which would return the best prediction accuracies for those specific classifiers. This subset of genes can be found in Table 4 . The prediction accuracies are summarized in Table 3 . The results of the prediction accuracies shown in Table 3 , are similar to those obtained in the analysis with the whole set of 70 genes, exception made to the meta-profiles classifier wich presents here a considerably lower prediction accuracy. Although this result might suggest a more reliable result for the prediction ability of the classifiers since overfitting is reduced, we need to stress that this subset of genes was a result of a specific feature selection for the classification approach in [5] .
Analyzing different Time-Points
In this case study, the assessment of the response class is carried only after two years of treatment with IFN-β. When using all the available time-points to classify the patients, we lose the prediction ability, in the strict sense of the word, as we do not anticipate the clinical outcome. In order to achieve this goal, we applied our classifiers to data containing a different number of time-points, ranging from only 3 to all 7 time-points. Note that CCC-biclustering requires a discretized dataset, and when discretization is based on variations between time-points, as is the case, we have t − 1 symbols, t being the number of time-points. This means that for 2 time-points, for example, we have only one symbol, rendering the biclustering trivial. Another consequence of this analysis is that, while reducing the number of time-points in the pursuit of a more realistic prognosis, the chances of overfitting are highly increased. Figure 5 shows the results obtained for different classifiers when applied to different sets of time-points. It is clear that the best performing classifier is always the meta-profiles method, and that the prediction accuracy lowers for less time-points, except for the set of 3 time-points, where it rises to a maximum value. Although the prediction accuracy obtained reaches 100% for the best 90% of biclusters, we have to state that, when reducing the number of time-points, we are increasing the chances of overfitting. Nevertheless, we note that these findings are supported by the results of Lin et al [4] , in which, for several genes such as IFN-gRa, STAT1, STAT2 and MX1, the averaged log expression of bad responders clearly separates from the one of the good responders, from 3 to 6 months (time-point 2 to 3). Figure 6 shows the average normalized expression for these genes. We also identify such differences between the average expression of good and bad responders, especially for the transition from time-point 2 to 3. 
Analyzing Biclusters and Genes
An interesting feature of the proposed classifiers is the possibility to analyze the genes associated with the most class-discriminant biclusters. Ideally, the genes used by an ideal classifier would help to understand the different mechanisms characterizing good and bad responders.
As an example, for the meta-profiles classifier, the most class-discriminant meta-profiles are the ones with the most unbalanced class proportions (in fact, they correspond to the ones with the proportion of good responders higher than a given threshold). Since a meta-profile represents a set of biclusters with similar expression profiles, we computed the number of times each gene was contained in that set of biclusters, with the goal of finding the most common ones. We expect these genes help to understand the differences within the bad responders, since this would be of great interest in this case study.
In order to choose the most common genes along the set of the most discriminant biclusters (obtained with the meta-profiles method), we computed the number of times each of the 70 genes was present in those biclusters. Then, we selected the genes for which the number of hits was higher than the sum of the mean and standard deviation of the whole set of gene hits. The genes found with this method are listed in Table 4 , together with the genes selected by Lin et al. [4] and Costa et al. [5] , using the respective algorithms of feature selection. Note that our method is based on a posterior analysis of the data, to find the most promising genes, whereas the genes selected in [4, 5] are based on feature selection prior to the classification. Table 4 : Selected genes in [4, 5] versus most discriminative genes used in the meta-profiles classifier. Table 4 shows that our results with three time-points found the three genes found by Lin et al [4] with the same time-points, together with other genes. When comparing the results with all the seven time-points, we retrieved all the genes found by Lin et al. [4] , except two (IL-4Ra and MAP3K1), although these were close to the selection threshold. The comparison between our results and the genes selected by Costa et al. [5] returned a number of common genes, such as Caspase 2, Caspase 3, Caspase 10, Jak2 and BAX. Since the first 4 genes are also selected by the algorithm of Lin et al. [4] , we take this result as a support for further investigation at the genetic level towards the discrimination between good and bad responders to IFN-β treatment.
Selected Genes

Availability
All the proposed biclustering-based classifiers were coded in Java, and are available through a self-developed Java Application with a GUI (Graphical User Interface), providing the possibility to reproduce the results shown in this paper, and allowing the user to classify new time series datasets. The software and the datasets used are available at: http://www.kdbio. inesc-id.pt/software/biclassifier.
Conclusions
Several features of the data can explain some of the challenges faced in the development of biclustering-based classifiers. These include the class unbalance, biasing the prediction towards the good responders, and the reduced number of time-points when compared to the number of genes, possibly resulting in data overfitting. A possible solution to overcome this issue lies on feature selection prior to biclustering, eliminating non-discriminative genes. However, when we applied our classifiers to the reduced set of genes obtained by Costa et al [5] , the results are similar to those obtained with the whole original dataset. The exception is the meta-profiles method, which presents a considerably lower prediction accuracy in the 17 genes scenario. Although this reduced set of genes leads to a reduction of overfitting, we note again that this set of genes was obtained by a feature selection algorithm designed for a specific classifier. Additionally, a common problem to clinical time series analyzes is the reduced number of patients, also introducing important inconsistencies (especially when using a k-fold CV scheme, with k small, causing a loss of a significant number of training instances).
The developed biclustering-based classifiers revealed potentialities and challenges. The timelag consideration was seen to improve significantly the prediction accuracy (p-value = 0.0025, paired t-test). Including the possibility of different state duration (a given patient might remain in an expression state longer than the others), taking fully into account the patient-specific response rate, would probably improve the classifier's performance. Other similarity measures between biclusters or sets of biclusters shall be also explored, to allow the (ideally direct) computation of the score between patients. We note also that, to our knowledge, biclustering has never been used before in classification of clinical expression time series, and kNN was widely shown to outperform other classifiers in classification problems with time series [12] .
Another aspect focused was the study of the genes/time-points involved in the most classdiscriminative biclusters. In prediction instead of classification, it is important to be able to predict the patient's response as soon as possible. Our analysis of different sets of time-points showed a decrease in the prediction accuracies as we went backwards from all 7 time-points to only 4. However, when using the first 3 time-points, as supported by Lin et al [4] , we could see an increase of the classifiers' performance, even reaching a perfect classification with the meta-profiles method for the 90% best biclusters. The posterior analysis of the most common genes in the set of most class-discriminant biclusters also showed interesting results. The genes found to be most promising in explaining the expression differences between bad responders, include genes such as Caspase 2, Caspase 3, Caspase 10 and Jak2, promising genes potentially contributing to new insights on the response to IFN-β treatment [4, 5] .
Finally, the proposed biclustering-based classifiers revealed potentialities that should be further explored in other (clinical) time series classification problems (ideally with more instances and/or time-points) and other data mining tasks. We believe their interpretability is a key advantage over other classifiers in prognostic prediction and other biomedical problems.
